Cardiac Rhythm Management Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Cardiac Rhythm Management (CRM) is a procedure to manage proper functioning of the heart. CRM can be accomplished using devices such as, defibrillators, pacemakers, and cardiac resynchronization therapy devices among others. CRM helps in accurate monitoring and treatment in patients suffering from heart disease, strokes, and high blood pressure. These CRM devices are used in hospitals, and home & ambulatory care for enhanced treatment.

MARKET SCOPE

The "Global Cardiac Rhythm Management Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cardiac rhythm management market with detailed market segmentation by product, end user and geography. The report provides key statistics on the market status of the leading cardiac rhythm management market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product, the global cardiac rhythm management market is segmented into defibrillators, pacemakers, and cardiac resynchronization therapy devices. The defibrillators is segmented into implantable cardioverter defibrillators (ICDS), and external defibrillators (ED). Pacemakers is segmented into implantable pacemakers (ICPS), and external pacemakers.
  
•   On the basis of end user, the market is segmented into hospitals, home and ambulatory care, and other.
  
  

MARKET DYNAMICS

Drivers

•   Increasing Prevalence of Cardiovascular Disorders
  
•   Technological Advancements
  
•   Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring
  

Restraints

•   High Cost of Devices
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cardiac rhythm management market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cardiac rhythm management market in these regions.

IMPACT OF COVID-19 ON CARDIAC RHYTHM MANAGEMENT MARKET

The COVID-19 pandemic has impacted all industries, including cardiac rhythm management market. Market players have experienced decline sales in cardiac rhythm management segments due to the delay in cardiovascular procedures. For instance, in 2021, Medtronic experienced a 12% decrease in its cardiac rhythm management devices segment. The decline was majorly experienced in ICDs, CRT-Ds, and pacemaker segments. Such factors negatively affected the growth of the market for cardiac rhythm management devices.

MARKET PLAYERS

The report covers key developments in the cardiac rhythm management market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cardiac rhythm management market are anticipated to lucrative growth opportunities in the future with the rising demand for Cardiac Rhythm Management in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Cardiac Rhythm Management market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   ZOLL Medical Corporation
  
•   BIOTRONIK
  
•   Medtronic
  
•   Boston Scientific Corporation
  
•   Koninklijke Philips N.V.
  
•   Abbott
  
•   LivaNova PLC
  
•   Schiller
  
•   Abiomed
  
•   MicroPort Scientific Corporation
  
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Cardiac Rhythm Management Report Scope